1. Carlsmed will report Q2 2025 financial results on August 28. 2. A conference call is scheduled for 1:30 PM PT on the same day. 3. Carlsmed focuses on AI-enabled personalized spine surgery technology to improve outcomes.
Upcoming financial results may highlight growth and innovation in a promising sector.
Earnings reports can significantly influence stock prices, especially in growth industries.
The Q2 report and conference call may lead to immediate market reactions.
CARLSBAD, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (NASDAQ:CARL), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025. Management will also host a conference call and concurrent webcast starting at 1:30 PM Pacific Time.
Conference Call Information
To participate in this event, dial in approximately 5 to 10 minutes before the start of the conference call.
Event Date: Thursday, August 28, 2025
Time: 1:30 PM Pacific Time
Participant Registration: https://register-conf.media-server.com/register/BI48d0cdca88dd4be5ad645de9962d27c3
A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website here.
About Carlsmed
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com
